Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NHP2 non-histone chromosome protein 2-like 1 pseudogene (ENSG00000230276) is classified as a pseudogene, meaning it is a segment of DNA that resembles a functional gene but has lost its protein-coding ability due to mutations or truncations[1][2][4]. This pseudogene is homologous to the NHP2 non-histone chromosome protein 2-like 1, which in other organisms may play roles in chromosome structure and gene regulation, but in this case, it does not encode a functional protein. Pseudogenes can sometimes have regulatory roles at the RNA level (for example, as antisense transcripts or siRNA precursors in gene silencing)[2][6], but there is no evidence that this particular pseudogene is a therapeutic target, nor that it has a distinct functional role in health or disease. Its existence is primarily as a genetic relic, with any minor functions speculative and unsupported for this entry.
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NHP2 non-histone chromosome protein 2-like 1 pseudogene (null).